Improving the understanding of originator and biosimilar biologics among healthcare providers in Saudi Arabia

The loss of patentability of many originator biologics has led to the rapid introduction of biosimilar agents. The anticipated economic benefit of introducing such agent has been accompanied by vagueness surrounding their biotechnology, approval requirements, positioning in treatment paradigms and p...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Saudi Pharm J
मुख्य लेखकों: Omair, Mohammed A., Alhawassi, Tariq, Alwaihibi, Munira, Aldrees, Ghada, Mosli, Mahmoud, Asser, Wesam M., Alharaibi, Maryam A., Alotaibi, Atheer T., Bintaleb, Doaa A., Alharbi, Najah K., Alotaibi, Ahmed Z., Alshammari, Wajed A., Alanazi, Nouf, Asiri, Ali M., Almadany, Rana, Al Rayes, Hanan, Al-Thunian, Turki, Alotaibi, Moureq, Al Jazaeri, Abdulrazaq
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Elsevier 2020
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783213/
https://ncbi.nlm.nih.gov/pubmed/33424270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2020.11.008
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन